• In support of heterogeneity in Alzheimer's disease (AD), the existence of clinical and biologic subtypes has been claimed. We have investigated this claim by a statistical analysis of the relationships between the number of neurons in nucleus locus ceruleus (nLC), cortical levels of neurotransmitters, number of cortical plaques and tangles, and age. We separated AD patients into two groups: AD-1, with a less severe loss of nLC neurons; and AD-2, with a greater loss. The AD-2 cases were associated with less choline acetyltransferase activity, smaller concentrations of somatostatin and norepinephrine, and more plaques and tangles in the cerebral cortex. Although the mean age at death was less and the duration of dementia was greater in AD-2 patients than in AD-1 patients, the differences in these age-related variables were not significant. Further evidence of heterogeneity came from discriminant function analyses based on nLC neuronal counts and age at death. These findings, suggesting two subtypes of AD, suggest heterogeneity.
Bondareff W, Mountjoy CQ, Roth M, Rossor MN, Iversen LL, Reynolds GP. Age and Histopathologic Heterogeneity in Alzheimer's Disease: Evidence for Subtypes. Arch Gen Psychiatry. 1987;44(5):412–417. doi:10.1001/archpsyc.1987.01800170026005
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: